Literature DB >> 2265476

Measurement of chemically induced cell proliferation in rodent liver and kidney: a comparison of 5-bromo-2'-deoxyuridine and [3H]thymidine administered by injection or osmotic pump.

S R Eldridge1, L F Tilbury, T L Goldsworthy, B E Butterworth.   

Abstract

Different labeling methods for quantitating cell proliferation were evaluated in livers and kidneys of control and chemically treated mice and rats. The percentage of cells in S-phase (labeling indices) were compared in tissues of animals given either 5-bromo-2'-deoxyuridine (BRDU) or [3H]thymidine. These DNA precursor labels were delivered either by a single i.p. injection 2 h prior to killing the animals or via the s.c. implanted osmotic pump for 3 or 6 days. B6C3F1 mice and male F344 rats were exposed to either a peroxisome proliferator and hepatocarcinogen, Wy-14,643 (WY), in the diet at 0.1% for up to 5 days, or a non-genotoxic mouse liver and male rat kidney carcinogen, 1,4-dichlorobenzene (DCB), in corn oil by gavage for up to 5 days in mice (600 mg/kg/day) or up to 3 weeks in rats (300 mg/kg/day, 5 days per week). Labeling indices (LIs) in the liver and kidney were similar in BRDU- and [3H]thymidine-labeled mice and rats. Cell proliferation was increased in livers of both species of WY- and DCB-treated animals when compared to controls. After 4 days of chemical treatment with continuous administration of a DNA precursor label during the last 3 days of treatment, LIs in controls, DCB- and WY-treated mouse livers were 0.7, 19 and 17% for BRDU and 0.9, 15 and 13% for [3H]-thymidine respectively. Furthermore, BRDU and [3H]-thymidine labeled the same population of cells as revealed by similar patterns of cell labeling in the livers and kidneys of treated animals. The LI for BRDU- and [3H]thymidine-labeled renal proximal tubular cells was 7.7 and 8.0% respectively, in rats receiving DCB for 4 days and DNA precursor label during the last 3 days of treatment, while the LI for controls was 4.3 and 3.7% respectively. The renal proximal tubular cell LI increased to 11% in BRDU-labeled rats treated with DCB for 3 weeks. LIs in both liver and kidney were greatest in control and treated animals that received the DNA precursor label via osmotic pumps for 6 days, and least in 2 h pulse-labeled animals. However, induction of hepatic LI in treated over control animals was greatest for treated animals labeled for 3 days. These results demonstrate comparable cell labeling of cells in S-phase with either BRDU and [3H]thymidine labeling methods. BRDU presents no radioactive containment problems, and results are obtained more rapidly than [3H]thymidine.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2265476     DOI: 10.1093/carcin/11.12.2245

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  28 in total

1.  Hyperproliferative hepatocellular alterations after intraportal transplantation of thyroid follicles.

Authors:  F Dombrowski; L Klotz; H J Hacker; Y Li; D Klingmüller; K Brix; V Herzog; P Bannasch
Journal:  Am J Pathol       Date:  2000-01       Impact factor: 4.307

2.  An estrogen receptor pathway regulates the telogen-anagen hair follicle transition and influences epidermal cell proliferation.

Authors:  H S Oh; R C Smart
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-29       Impact factor: 11.205

3.  Dose-response analysis of epigenetic, metabolic, and apical endpoints after short-term exposure to experimental hepatotoxicants.

Authors:  Isabelle R Miousse; Lynea A Murphy; Haixia Lin; Melissa R Schisler; Jinchun Sun; Marie-Cecile G Chalbot; Radhakrishna Sura; Kamin Johnson; Matthew J LeBaron; Ilias G Kavouras; Laura K Schnackenberg; Richard D Beger; Reza J Rasoulpour; Igor Koturbash
Journal:  Food Chem Toxicol       Date:  2017-05-08       Impact factor: 6.023

4.  Comparative uterotrophic effects of endoxifen and tamoxifen in ovariectomized Sprague-Dawley rats.

Authors:  Karen M Schweikart; Sandy R Eldridge; Stephanie L Safgren; Toufan Parman; Joel M Reid; Matthew M Ames; Matthew P Goetz; Myrtle A Davis
Journal:  Toxicol Pathol       Date:  2014-03-26       Impact factor: 1.902

5.  Dual inhibition of both the epidermal growth factor receptor and erbB2 effectively inhibits the promotion of skin tumors during two-stage carcinogenesis.

Authors:  Kaoru Kiguchi; Takuya Kitamura; Tricia Moore; Mohammad Rumi; Hsiang-Chun Chang; Devon Treece; Lynnsie Ruffino; Kevin Connolly; John DiGiovanni
Journal:  Cancer Prev Res (Phila)       Date:  2010-08-03

6.  Juxtaposition of peroxisomes and chromosomes in mitotic hepatocytes following methyl clofenapate administration to rats.

Authors:  A R Soames; J R Foster
Journal:  Int J Exp Pathol       Date:  1994-12       Impact factor: 1.925

Review 7.  The application of 5-bromodeoxyuridine in the management of CNS tumors.

Authors:  A Freese; D O'Rourke; K Judy; M J O'Connor
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

8.  Proliferation indices as molecular pharmacodynamic endpoints in evaluation of anticancer drug effect in human solid tumors.

Authors:  J R Weaver; Y Gan; J L Au
Journal:  Pharm Res       Date:  1998-10       Impact factor: 4.200

9.  Cell proliferation induced in the kidneys and livers of rats and mice by short term exposure to the carcinogen p-dichlorobenzene.

Authors:  T Umemura; K Tokumo; G M Williams
Journal:  Arch Toxicol       Date:  1992       Impact factor: 5.153

10.  Paracrine overexpression of insulin-like growth factor-1 enhances mammary tumorigenesis in vivo.

Authors:  Krisztina Kovács de Ostrovich; Isabel Lambertz; Jennifer K L Colby; Jie Tian; Joyce E Rundhaug; Dennis Johnston; Claudio J Conti; John DiGiovanni; Robin Fuchs-Young
Journal:  Am J Pathol       Date:  2008-08-07       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.